The Greater Cannabis Company, Inc. (GCAN)
Stock Price:
$0.0079 USD
0.0000 (0.00%)
Updated Jul 8, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
599,474 |
| Revenue (ttm) |
7,120 |
| Net Income (ttm) |
-2.72M |
| Shares Out |
75.88M |
| EPS (ttm) |
-0.07 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 8, 2020 |
| Last Price |
$0.0079 |
| Previous Close |
$0.0079 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
- |
| Day's Range |
0.0058 - 0.0079 |
| Day's Volume |
0 |
| 52-Week Range |
0.0036 - 0.1500 |
More Stats
| Market Cap |
599,474 |
| Enterprise Value |
1.10M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
75.88M |
| Float |
70.49M |
| EPS (basic) |
-0.08 |
| EPS (diluted) |
-0.07 |
| FCF / Share |
-0.01 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
84.20 |
| PB Ratio |
n/a |
| Revenue |
7,120 |
| Operating Income |
-524,343 |
| Net Income |
-2.72M |
| Free Cash Flow |
-296,282 |
| Net Cash |
-495,727 |
| Net Cash / Share |
-0.01 |
| Gross Margin |
-927.04% |
| Operating Margin |
-7,364.37% |
| Profit Margin |
-38,227.70% |
| FCF Margin |
-4,161.26% |
| ROA |
-95.16% |
| ROE |
n/a |
| ROIC |
311.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 0.01 | 0.10 | - | - |
| Revenue Growth | -92.53% | 45533.97% | - | - |
| Gross Profit | - | 0.10 | - | - |
| Operating Income | -0.53 | -0.19 | -0.62 | -0.10 |
| Net Income | -1.65 | -0.84 | -0.81 | -0.10 |
| Shares Outstanding | 34.98 | 29.96 | 27.98 | 26.91 |
| Earnings Per Share | -0.05 | -0.03 | -0.03 | - |
| Operating Cash Flow | -0.29 | -0.10 | -0.04 | - |
| Free Cash Flow | -0.29 | -0.10 | -0.04 | - |
| Cash & Equivalents | 0.02 | 0.06 | 0.00 | 0.00 |
| Total Debt | 0.66 | 0.32 | 0.11 | 0.10 |
| Net Cash / Debt | -0.63 | -0.27 | -0.11 | -0.10 |
| Assets | 0.05 | 0.15 | - | - |
| Liabilities | 1.60 | 0.71 | 0.39 | 0.11 |
| Book Value | -1.55 | -0.56 | -0.39 | -0.11 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
The Greater Cannabis Company, Inc. |
| Country |
United States |
| Employees |
2 |
| CEO |
Aitan Zacharin |
Stock Information
| Ticker Symbol |
GCAN |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
OTCMKTS: GCAN |
Description
The Greater Cannabis Company, Inc., a biopharmaceutical company, focuses on the development and commercialization of cannabinoid delivery systems. It holds the license of Eluting Transmucosal Patch platform for non-invasive drug delivery in the cannabis field. The company is based in Baltimore, Maryland.